Hyperpigmentation and melasma treatment
BPC-157: Best for nerve regeneration and pain Why it helps nerve pain: Promotes nerve regeneration Reduces nerve inflammation Protects nerves from further damage Improves nerve function Best for: Diabetic neuropathy Post-injury nerve pain Sciatica (nerve compression pain) Peripheral neuropathy Nerve damage from surgery Dosing: 250-500mcg twice daily Injectable systemic (abdomen or thighs) 8-16 weeks minimum Nerve healing is slow - be patient Timeline: Week 2-4: Slight pain reduction Week 6-8: Noticeable improvement Week 12-16: Significant pain relief May need 6+ months for severe neuropathy KPV: Alternative for inflammatory nerve pain Why KPV works: Potent anti-inflammatory Reduces inflammatory cytokines affecting nerves Calms immune system response Good for autoimmune-related nerve pain Best for: Inflammatory neuropathy Autoimmune nerve damage When inflammation is primary cause Dosing: 500-1,000mcg daily injectable Or oral for systemic inflammation 8-12 weeks See our KPV peptide dosage guide and KPV peptide benefits
BPC 157
Customs and Taxes It is important to remember that international orders may be subject to GST/HST depending on your province
The following are general categories of individuals who explore Cerebrolysin therapy in clinical settings: Adults experiencing age-related cognitive decline, mild memory concerns, or subjective brain fog Patients in post-stroke or post-TBI rehabilitation seeking additional neurological support alongside standard rehabilitation Individuals with early-stage neurodegenerative conditions, explored in coordination with existing standard-of-care approaches High-performing professionals, executives, or biohackers seeking evidence-based cognitive optimization Patients pursuing proactive brain health and longevity protocols with medical supervision Cerebrolysin peptide therapy at Robertson Wellness and Aesthetics, Beverly Hills At Robertson Wellness and Aesthetics in Beverly Hills, Cerebrolysin is offered as part of a fully personalized peptide therapy program
3.3 Female reproductive system cancer 3.3.1 Breast cancer (BC) Breast cancer is the most common cancer in women and the leading cause of cancer death
